Verification evidence is still being completed.
PDF / print export
AstraZeneca Gothenburg
Gothenburg, Sweden
- Verified lead
- Pascal Soriot
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Biopharmaceutical R&D, Cardiometabolic Science, and Translational Discovery
- Review cycle
- May 2026
- Full address
- Professional N/A
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official AstraZeneca senior executive team page confirming Pascal Soriot as Chief Executive Officer.
- Editorial note
- AstraZeneca's Gothenburg site appears in the Swedish directory layer as an officially described strategic science centre backed by current executive-team disclosure.
Biopharmaceutical R&D, Cardiometabolic Science, and Translational Discovery
Global pharmaceutical quality systems, Research and development governance
AstraZeneca's Gothenburg site appears in the Swedish directory layer as an officially described strategic science centre backed by current executive-team disclosure.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Gothenburg, Sweden
AstraZeneca Gothenburg
Biopharmaceutical R&D, Cardiometabolic Science, and Translational Discovery · Global biopharmaceutical research and development
AstraZeneca's Gothenburg site appears in the Swedish directory layer as an officially described strategic science centre backed by current executive-team disclosure.
- Lead
- Pascal Soriot (verified ↗)
- Address
- Not yet on record (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 15 Mar 2026 (3mo ago)
- Scale
- Global biopharmaceutical research and development
- Capabilities
- Cardiovascular, Renal and Metabolism Research · Oncology R&D · Biologics and Data Science Integration
- Founded
- 1999
- Headcount
- 10000+
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Pascal Soriot
Chief Executive Officer
Full addressProfessional N/A
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
AstraZeneca Gothenburg location page describing the city's strategic science-centre campus.
Open sourceGlobal biopharmaceutical research and development
Gothenburg, Sweden. Biopharmaceutical R&D, Cardiometabolic Science, and Translational Discovery. Review completed on 15 Mar 2026.
Swedish pharmaceutical oversight and AstraZeneca global R&D governance
Global pharmaceutical quality systems, Research and development governance
Biopharmaceutical R&D, Cardiometabolic Science, and Translational Discovery
AstraZeneca's Gothenburg site appears in the Swedish directory layer as an officially described strategic science centre backed by current executive-team disclosure.
Editorial note
AstraZeneca's Gothenburg site appears in the Swedish directory layer as an officially described strategic science centre backed by current executive-team disclosure.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Cardiovascular, Renal and Metabolism Research
Oncology R&D
Biologics and Data Science Integration
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Discovery biology laboratories
Translational data-science platforms
Process and analytical development suites
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
15 Mar 2026: Executive identity confirmed via official management disclosure.
15 Mar 2026: Trust review remains in progress.
FAQ
Frequently asked questions
- Where is AstraZeneca Gothenburg located?
- AstraZeneca Gothenburg is based in Gothenburg, Sweden.
- Who runs AstraZeneca Gothenburg?
- AstraZeneca Gothenburg is led by Pascal Soriot, Chief Executive Officer. Verified 15 Mar 2026.
- What does AstraZeneca Gothenburg do?
- AstraZeneca's Gothenburg site appears in the Swedish directory layer as an officially described strategic science centre backed by current executive-team disclosure. Core capabilities: Cardiovascular, Renal and Metabolism Research, Oncology R&D, Biologics and Data Science Integration.
Editorial context
Related technical briefs
Briefs that name Gothenburg as a covered market or city.